Prof. Paul Vaaler Quoted in Star Tribune About Buy-Up of Solventum Stock Shares

Professor Paul Vaaler, John and Bruce Mooty Chair in Law and Business, was quoted in the Star Tribune discussing the buying up of Solventum stock in recent days by New York-based hedge fund and investment management firm Trian Partners. Solventum was spunoff by 3M’s health care business in April 2024 and makes medical and surgical devices, dental products, health information systems and purification-filtration products. Prof. Vaaler said it’s hard to gauge Trian’s plans, given Solventum’s short history as a standalone, publicly traded company. “They’ve indicated intentions, but they’re pretty general,” he said.